Higher afamin levels are significantly associated with the markers of obesity and the obesity-linked disorders such as metabolic syndrome, type 2 diabetes, and gestational diabetes (Figure 4) [96,97]. Here, AFM is linked to obesity due to melanocortin 4 receptor deficiency.